(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are XXL, PHAROL, and AZERION.

Financial Asset	Price	Change	Updated (EST)
XXL (XXL.OL)	1.07	57.35%	2023-10-11 12:44:27
PHAROL (PHR.LS)	0.05	14.56%	2023-10-11 12:23:51
AZERION (AZRN.AS)	2.27	12.94%	2023-10-11 12:00:42
THUNDERBIRD (TBIRD.AS)	0.08	12.32%	2023-10-11 12:04:08
PCI BIOTECH HOLD (PCIB.OL)	1.35	8%	2023-10-11 12:42:07
EBUSCO HOLDING (EBUS.AS)	5.09	6.75%	2023-10-11 12:01:45
BERGENBIO (BGBIO.OL)	0.13	6.18%	2023-10-11 12:25:08
AKER HORIZONS (AKH.OL)	4.12	5.92%	2023-10-11 12:24:34
NEPI ROCKCASTLE (NRP.AS)	5.55	5.71%	2023-10-11 12:03:06
VIOHALCO (VIO.BR)	4.90	5.38%	2023-10-11 12:22:07

The three biggest losers today are BENEVOLENTAI, KITRON, and SALMONES CAMANCHAC.

Financial Asset	Price	Change	Updated (EST)
BENEVOLENTAI (BAI.AS)	0.80	-9.14%	2023-10-11 12:00:54
KITRON (KIT.OL)	33.50	-7.46%	2023-10-11 12:40:48
SALMONES CAMANCHAC (SACAM.OL)	35.20	-5.88%	2023-10-11 12:42:43
INPOST (INPST.AS)	10.09	-5.3%	2023-10-11 12:02:41
MEDISTIM (MEDI.OL)	195.00	-4.88%	2023-10-11 12:41:06
GEOJUNXION (GOJXN.AS)	0.71	-4.81%	2023-10-11 12:02:17
ATENOR (ATEB.BR)	12.25	-4.67%	2023-10-11 12:04:58
NORBIT (NORBT.OL)	48.70	-4.51%	2023-10-11 12:41:25
MITHRA (MITRA.BR)	1.23	-3.45%	2023-10-11 12:20:49
ATOS (ATO.PA)	5.07	-3.39%	2023-10-11 12:46:00

Winners today

1. XXL (XXL.OL)

57.35% Price Change

XXL ASA operates as a sports retailer. It offers sports equipment and sportswear for various sports, including running, football, golf, water sports, racket sports, and ice hockey; and fitness equipment, including treadmills and rowing machines, as well as food supplements and nutrition. The company also provides clothes for men, women, and children for baselayers, outerwear, casual wear, sportswear, and swimwear, as well as lifestyle shoes and winter shoes; outdoor and hunting products for fishing, wilderness living, and camping, such as tents, lavvos, sleeping bags, backpacks, cooking equipment as well as climbing gear; and hunting products, including firearms and ammunition, clothes, binoculars, optics, knives, and axes. In addition, it offers skis and ski accessories, such as shoes, poles, clothes, and other equipment for cross-country and downhill skiing, as well as snowboarding; high-end and everyday bikes comprising hybrid bikes, mountain bikes, city bikes, and electric bikes for children, women, and men; and bike equipment, such as helmets, shoes, spare parts, and clothes. Further, the company provides products that connect technology and sports/outdoor activities, including sport watches, action cameras, drones, GPS, earplugs and headphones, portable loudspeakers, sunglasses, pulse meters, power banks, and cycle computers. It operates stores in Norway, Sweden, and Finland, as well as e-commerce websites, such as xxl.no, xxl.se, xxl.fi, and xxl.dk. The company was founded in 2000 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with XXL rising 57.35% to €1.07 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.2% to €1,293.20.

Earnings Per Share

As for profitability, XXL has a trailing twelve months EPS of kr-1.87.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.05%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, XXL’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

XXL’s EBITDA is 0.43.

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.9%, now sitting on 8.4B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 200% and positive 33.3% for the next.

More news about XXL.

2. PHAROL (PHR.LS)

14.56% Price Change

Pharol, SGPS S.A., through its investment in Oi, S.A., provides fiber to the home services to residential customers in Brazil. The company was formerly known as Portugal Telecom, SGPS, SA and changed its name to Pharol, SGPS S.A. in May 2015. Pharol, SGPS S.A. was founded in 1877 and is headquartered in Lisbon, Portugal.

PSI ended the session with PHAROL jumping 14.56% to €0.05 on Wednesday, following the last session’s upward trend. PSI jumped 1.41% to €6,142.55, after four consecutive sessions in a row of gains, on what was an all-around up trend trading session today.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.04%.

Yearly Top and Bottom Value

PHAROL’s stock is valued at €0.05 at 22:40 EST, way below its 52-week high of €0.08 and way above its 52-week low of €0.04.

Volume

Today’s last reported volume for PHAROL is 4411070 which is 370.81% above its average volume of 936902.

Moving Average

PHAROL’s worth is way above its 50-day moving average of €0.04 and under its 200-day moving average of €0.05.

More news about PHAROL.

3. AZERION (AZRN.AS)

12.94% Price Change

Azerion Group N.V. operates a digital entertainment and media platform worldwide. Its integrated platform offers technology solutions to automate the purchase and sale of digital advertising inventory for advertisers, publishers, and game creators, as well as to develop, publish, distribute, and operate online social and casual games, and digital content. The company was founded in 2014 and is headquartered in Schiphol-Rijk, the Netherlands.

AEX-Index ended the session with AZERION jumping 12.94% to €2.27 on Wednesday, after two successive sessions in a row of gains. AEX-Index slid 0.15% to €737.78, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, AZERION has a trailing twelve months EPS of €-0.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.76%.

Volume

Today’s last reported volume for AZERION is 186141 which is 137.56% above its average volume of 78353.

Yearly Top and Bottom Value

AZERION’s stock is valued at €2.27 at 22:40 EST, way below its 52-week high of €7.36 and way above its 52-week low of €1.28.

More news about AZERION.

4. THUNDERBIRD (TBIRD.AS)

12.32% Price Change

Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.

AEX-Index ended the session with THUNDERBIRD rising 12.32% to €0.08 on Wednesday, following the last session’s upward trend. AEX-Index slid 0.15% to €737.78, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.02.

PE Ratio

THUNDERBIRD has a trailing twelve months price to earnings ratio of 3.88. Meaning, the purchaser of the share is investing €3.88 for every euro of annual earnings.

More news about THUNDERBIRD.

5. PCI BIOTECH HOLD (PCIB.OL)

8% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD jumping 8% to €1.35 on Wednesday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 0.2% to €1,293.20, after two successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.74.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PCI BIOTECH HOLD’s EBITDA is -4.54.

Volatility

PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.63%, a negative 1.22%, and a positive 3.40%.

PCI BIOTECH HOLD’s highest amplitude of average volatility was 4.84% (last week), 2.61% (last month), and 3.40% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 84.4%, now sitting on 2.79M for the twelve trailing months.

More news about PCI BIOTECH HOLD.

6. EBUSCO HOLDING (EBUS.AS)

6.75% Price Change

Ebusco Holding N.V., together with its subsidiaries, develops, manufactures, and distributes zero emission buses, batteries, and charging systems in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. It also sells ancillary products and services; and provides electric vehicle ecosystem repair and maintenance services. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.

AEX-Index ended the session with EBUSCO HOLDING rising 6.75% to €5.09 on Wednesday, after three successive sessions in a row of gains. AEX-Index slid 0.15% to €737.78, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-0.92.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.25%.

Volatility

EBUSCO HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.79%, a negative 0.70%, and a positive 2.61%.

EBUSCO HOLDING’s highest amplitude of average volatility was 2.95% (last week), 2.95% (last month), and 2.61% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 116.25M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EBUSCO HOLDING’s stock is considered to be oversold (<=20).

More news about EBUSCO HOLDING.

7. BERGENBIO (BGBIO.OL)

6.18% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 6.18% to €0.13 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.2% to €1,293.20.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Volume

Today’s last reported volume for BERGENBIO is 52307000 which is 51.88% above its average volume of 34437600.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was 1.75%, 0.59%, and 4.75%.

BERGENBIO’s highest amplitude of average volatility was 3.57% (last week), 3.02% (last month), and 4.75% (last quarter).

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr0.13 at 22:40 EST, way under its 52-week high of kr13.03 and way above its 52-week low of kr0.08.

More news about BERGENBIO.

8. AKER HORIZONS (AKH.OL)

5.92% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA is a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS rising 5.92% to €4.12 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.2% to €1,293.20.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-9.5.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AKER HORIZONS’s stock is considered to be oversold (<=20).

Volatility

AKER HORIZONS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.18%, a negative 0.71%, and a positive 3.32%.

AKER HORIZONS’s highest amplitude of average volatility was 4.27% (last week), 3.88% (last month), and 3.32% (last quarter).

More news about AKER HORIZONS.

9. NEPI ROCKCASTLE (NRP.AS)

5.71% Price Change

NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe (CEE), with presence in nine countries and an investment portfolio of €5.8 billion as at 31 December 2021. The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise. Geographically diverse management skills allow NEPI Rockcastle to pursue CEE property opportunities efficiently, benefiting from a strategic advantage in the acquisition, development and management of properties. NEPI Rockcastle owns and operates 52 retail properties (excluding joint venture) which attracted 244 million visits in 2021 (325 million visits in 2019). With group-level management of tenant relationships and a focus on cross-country collaboration, the Group is the leading strategic partner for major retailers targeting CEE countries. The Group's financial strategy includes maintaining a profile of adequate liquidity, conservative gearing, and a diverse debt structure, which combines secured and unsecured bank debt with unsecured bonds listed on the Irish Stock Exchange. NEPI Rockcastle is investment-grade rated by Standard & Poor's (BBB, stable outlook) and Fitch (BBB, positive outlook). NEPI Rockcastle's shares are listed on the Johannesburg Stock Exchange (“JSE”), Euronext Amsterdam (“Euronext”) and A2X. The Group voluntarily distributes at least 90% of its distributable earnings on a semi-annual basis.

AEX-Index ended the session with NEPI ROCKCASTLE rising 5.71% to €5.55 on Wednesday, following the last session’s downward trend. AEX-Index slid 0.15% to €737.78, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, NEPI ROCKCASTLE has a trailing twelve months EPS of €0.85.

PE Ratio

NEPI ROCKCASTLE has a trailing twelve months price to earnings ratio of 6.53. Meaning, the purchaser of the share is investing €6.53 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NEPI ROCKCASTLE’s stock is considered to be overbought (>=80).

More news about NEPI ROCKCASTLE.

10. VIOHALCO (VIO.BR)

5.38% Price Change

Viohalco S.A., through its subsidiaries, manufactures, and sells aluminium, copper, cables, and steel and steel pipe products worldwide. The company operates through seven segments: Aluminium, Cables, Copper, Steel, Steel Pipes, Real Estate, Other Activities. The Aluminium segment offers aluminium products, including coils, strips, sheets, and foils for various applications; and rolled and extruded products for construction, rigid and flexible packaging, transportation, household, industrial, architectural systems, and automotive applications, as well as lithographic coils. The Cables segment manufactures power and telecommunication cables, as well as enamelled wires and plastic and rubber compounds. The Copper segment provides copper tubes; copper and brass strips, sheets, discs and plates, and special copper alloy strips; copper bus bars and rods, brass rods and tubes, profiles and wires, copper alloy wire, and net; and cables and conductors, enamelled wires, and copper and aluminium wire rods, as well as plastic and rubber compounds. The Steel segment offers long, flat, and downstream steel products. The Steel Pipes segment provides steel pipes for the oil, gas, CO2, water transportation, and oil and gas extraction, as well as hollow structural sections for construction application. The Real Estate segment develops and manages large-scale commercial and industrial properties. The Other Activities segment produces products and solutions for the optimization of industrial and business processes. The company serves clients in building and construction, packaging, transportation, energy and power networks, heating, ventilation, air conditioning and refrigeration, water supply, telecommunications, printing, and other industrial sectors. Viohalco S.A. was incorporated in 1937 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with VIOHALCO jumping 5.38% to €4.90 on Wednesday, following the last session’s upward trend. BEL 20 rose 0.22% to €3,548.89, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, VIOHALCO has a trailing twelve months EPS of €0.37.

PE Ratio

VIOHALCO has a trailing twelve months price to earnings ratio of 13.24. Meaning, the purchaser of the share is investing €13.24 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.87%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 19, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 2.4%.

Volatility

VIOHALCO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.34%, a negative 1.62%, and a positive 2.27%.

VIOHALCO’s highest amplitude of average volatility was 3.58% (last week), 2.64% (last month), and 2.27% (last quarter).

Yearly Top and Bottom Value

VIOHALCO’s stock is valued at €4.90 at 22:40 EST, way under its 52-week high of €7.10 and way above its 52-week low of €3.45.

Revenue Growth

Year-on-year quarterly revenue growth declined by 9%, now sitting on 6.75B for the twelve trailing months.

More news about VIOHALCO.

Losers Today

1. BENEVOLENTAI (BAI.AS)

-9.14% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI sliding 9.14% to €0.80 on Wednesday while AEX-Index slid 0.15% to €737.78.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.97%.

More news about BENEVOLENTAI.

2. KITRON (KIT.OL)

-7.46% Price Change

Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.

Oslo Børs Benchmark Index_GI ended the session with KITRON sliding 7.46% to €33.50 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.2% to €1,293.20, after two successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, KITRON has a trailing twelve months EPS of kr2.77.

PE Ratio

KITRON has a trailing twelve months price to earnings ratio of 12.09. Meaning, the purchaser of the share is investing kr12.09 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.51%.

More news about KITRON.

3. SALMONES CAMANCHAC (SACAM.OL)

-5.88% Price Change

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. The company was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Compañía Pesquera Camanchaca S.A.

Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC dropping 5.88% to €35.20 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.2% to €1,293.20.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr4.87.

PE Ratio

SALMONES CAMANCHAC has a trailing twelve months price to earnings ratio of 7.23. Meaning, the purchaser of the share is investing kr7.23 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.89%.

Volume

Today’s last reported volume for SALMONES CAMANCHAC is 3245 which is 360.93% above its average volume of 704.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 98% and a negative 93.5%, respectively.

Sales Growth

SALMONES CAMANCHAC’s sales growth is negative 87.7% for the current quarter and negative 90.9% for the next.

Volatility

SALMONES CAMANCHAC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.53%, a negative 0.43%, and a positive 1.86%.

SALMONES CAMANCHAC’s highest amplitude of average volatility was 1.25% (last week), 1.66% (last month), and 1.86% (last quarter).

More news about SALMONES CAMANCHAC.

4. INPOST (INPST.AS)

-5.3% Price Change

InPost S.A., together with its subsidiaries, operates as an out-of-home e-commerce enablement platform providing parcel locker services in Europe. It operates through four segments: APM (automated parcel machines), To-Door, Mondial Relay, and International Other. The APM segment focuses on the delivery of parcels to automated parcel machines. The To-Door segment delivers parcels using door-to-door couriers. The Mondial Relay segment delivers parcels to automated parcel machines; and operates pick-up drop-off (PUDO) points in France, Spain, Belgium, the Netherlands, Luxembourg, and Portugal. The International Other segment delivers parcels to automated parcel machines in the United Kingdom and Italy. The company also provides fulfilment services; IT services; and e-Grocery, a delivery service for food and FMCG products through InPost Fresh app. InPost S.A. was founded in 1999 and is headquartered in Luxembourg, Luxembourg.

AEX-Index ended the session with INPOST falling 5.3% to €10.09 on Wednesday while AEX-Index dropped 0.15% to €737.78.

Earnings Per Share

As for profitability, INPOST has a trailing twelve months EPS of €0.18.

PE Ratio

INPOST has a trailing twelve months price to earnings ratio of 56.06. Meaning, the purchaser of the share is investing €56.06 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 76.84%.

Sales Growth

INPOST’s sales growth is 26.9% for the present quarter and 34.8% for the next.

Yearly Top and Bottom Value

INPOST’s stock is valued at €10.09 at 22:40 EST, way under its 52-week high of €11.96 and way above its 52-week low of €5.49.

Volume

Today’s last reported volume for INPOST is 186215 which is 32.5% below its average volume of 275895.

More news about INPOST.

5. MEDISTIM (MEDI.OL)

-4.88% Price Change

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with MEDISTIM falling 4.88% to €195.00 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.2% to €1,293.20.

Earnings Per Share

As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.33.

PE Ratio

MEDISTIM has a trailing twelve months price to earnings ratio of 30.81. Meaning, the purchaser of the share is investing kr30.81 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.9%.

More news about MEDISTIM.

6. GEOJUNXION (GOJXN.AS)

-4.81% Price Change

GeoJunxion N.V. manufactures and supplies digital maps, premium location content, and location intelligence services worldwide. The company provides location aware content products, including Digital Maps for use in routing, planning, and display services; Geo Location application programming interface (API) that addresses geocoding and time zones covering Europe and North America; and Geo Planning API, which provides time and distance matrices for logistics and resource planning applications, as well as premium location content products, such as Safety Alert Zone that concentrates on road safety by alerting mobility users; Eco Alert Zones, which includes dataset of regulated congestion, emission and restricted traffic zones for use in routing, planning, fleet management, display, real estate applications, and other sectors; and Health Alert Zones that contains COVID-19 related information. It also offers location intelligence services, which includes search and evaluation of location enabled content to enhance existing maps and/or routing applications; creating bespoke datasets; and producing outdoor venue plans for use in events, travel and tourism, real estate applications, last mile navigation and delivery, retail and distribution, and smart city applications, as well as operates GeoAlertsLive application. The company was formerly known as AND International Publishers N.V. GeoJunxion N.V. was founded in 1984 and is headquartered in Capelle aan den IJssel, the Netherlands.

AEX-Index ended the session with GEOJUNXION sliding 4.81% to €0.71 on Wednesday, after three sequential sessions in a row of losses. AEX-Index dropped 0.15% to €737.78, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, GEOJUNXION has a trailing twelve months EPS of €-0.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.12%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GEOJUNXION’s stock is considered to be overbought (>=80).

Volatility

GEOJUNXION’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.49%, a negative 1.02%, and a positive 4.48%.

GEOJUNXION’s highest amplitude of average volatility was 6.92% (last week), 4.45% (last month), and 4.48% (last quarter).

More news about GEOJUNXION.

7. ATENOR (ATEB.BR)

-4.67% Price Change

Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, the United Kingdom, and Romania. The company develops real estate projects, such as offices and residential buildings. Atenor SA was founded in 1910 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with ATENOR sliding 4.67% to €12.25 on Wednesday while BEL 20 jumped 0.22% to €3,548.89.

Earnings Per Share

As for profitability, ATENOR has a trailing twelve months EPS of €-9.45.

Volatility

ATENOR’s last week, last month’s, and last quarter’s current intraday variation average was a positive 7.66%, a negative 1.51%, and a positive 3.56%.

ATENOR’s highest amplitude of average volatility was 10.55% (last week), 6.37% (last month), and 3.56% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATENOR’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ATENOR is 8353 which is 37.67% above its average volume of 6067.

More news about ATENOR.

8. NORBIT (NORBT.OL)

-4.51% Price Change

Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. The company was founded in 1995 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORBIT dropping 4.51% to €48.70 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI slid 0.2% to €1,293.20, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, NORBIT has a trailing twelve months EPS of kr2.9.

PE Ratio

NORBIT has a trailing twelve months price to earnings ratio of 16.79. Meaning, the purchaser of the share is investing kr16.79 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.5%.

Volume

Today’s last reported volume for NORBIT is 24726 which is 31.5% below its average volume of 36101.

More news about NORBIT.

9. MITHRA (MITRA.BR)

-3.45% Price Change

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

BEL 20 ended the session with MITHRA dropping 3.45% to €1.23 on Wednesday, following the last session’s upward trend. BEL 20 rose 0.22% to €3,548.89, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-1.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -575.59%.

Moving Average

MITHRA’s value is way under its 50-day moving average of €2.10 and way below its 200-day moving average of €2.56.

Yearly Top and Bottom Value

MITHRA’s stock is valued at €1.23 at 22:40 EST, way below its 52-week high of €6.87 and way above its 52-week low of €1.11.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MITHRA’s stock is considered to be oversold (<=20).

More news about MITHRA.

10. ATOS (ATO.PA)

-3.39% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS sliding 3.39% to €5.07 on Wednesday, following the last session’s upward trend. CAC 40 fell 0.44% to €7,131.21, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-10.01.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATOS’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ATOS is 1099580 which is 33.9% below its average volume of 1663670.

Volatility

ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.18%, a negative 1.62%, and a positive 3.28%.

ATOS’s highest amplitude of average volatility was 6.27% (last week), 3.03% (last month), and 3.28% (last quarter).

More news about ATOS.

Stay up to date with our winners and losers daily report